Our principal finding is that while CD4+ and CD8+ TIL populations associate with improved OS in HNSCC, there was considerable heterogeneity in outcomes between different tumor anatomical subsites—previously unreported in the literature. Here, CD4 is linked to head and neck squamous cell carcinoma.